Content area

|
|

Genomisk medicin som forbrugervare

Forfatter(e)
Lasse Folkersen & Thomas Werge
Institut for Biologisk Psykiatri, Psykiatrisk Center Sct. Hans, Region Hovedstadens Psykiatri

Ugeskr Læger 2019;181:V11180789
Reference: 
Ugeskr Læger 2019;181:V11180789
Blad nummer: 

Lasse Folkersen & Thomas Werge:

Genomic medicine as consumer goods

Ugeskr Læger 2019;181:V11180789

In this review, current trends in personal genetics are covered. The main differences between the “classic” rare high-effect mutations vs. the combined effects of thousands of common, low-risk variants are outlined, and then we provide examples of possible clinical use of microarray-based genetic measurements of rare high-risk mutations, and diagnosis-specific polygenic risk scores. The aim of this review is to discuss the possible clinical relevance vs. the hyped and potentially harmful overinterpretations of direct-to-consumer genetics services.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Stefan Svendsen | 30/07
3 kommentarer
af Leo Kirkegaard Winther | 28/07
17 kommentarer
af Ann-Christina Skyttebo Scheffmann | 26/07
1 Kommentar
af Birger Kreutzfeldt | 23/07
10 kommentarer
af Susanne Mejlby Nielsen | 19/07
2 kommentarer
af Toke Seierøe Barfod | 17/07
1 Kommentar
af Betina Damsgaard | 12/07
1 Kommentar
af Preben G. Berthelsen | 12/07
1 Kommentar
af Eskild Boeskov | 11/07
6 kommentarer